Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Oct-31-22 | Oct-31-21 | Oct-31-20 | Oct-31-19 | Oct-31-18 | Oct-31-17 | Oct-31-16 | Oct-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Sales Channel, Net Sales to Unaffiliated Customers | 2,625.7 | 2,297.1 | 1,893.4 | 2,066.6 | 2,008.7 | 2,139.0 | | |
CooperVision | 2,243.3 | 599.6 | 518.8 | 1,972.9 | 573.9 | 531.8 | 1,577.2 | 1,487.8 |
CooperSurgical | 633.6 | 451.3 | 229.1 | 422.4 | 250.4 | 464.9 | 389.6 | 309.3 |
Total revenues [+] | 3,308.4 | 2,922.5 | 2,430.9 | 2,653.4 | 2,532.8 | 2,139.0 | 1,966.8 | 1,797.1 |
Products | 3,308.4 | 2,922.5 | 2,430.9 | 2,653.4 | 2,532.8 | 2,139.0 | | |
Revenue growth [+] | 13.2% | 20.2% | -8.4% | 4.8% | 18.4% | 8.8% | 9.4% | 4.6% |
Sales Channel, Net Sales to Unaffiliated Customers | 14.3% | 21.3% | -8.4% | 2.9% | -6.1% | | | |
CooperVision | 274.1% | 15.6% | -73.7% | 243.8% | 7.9% | -66.3% | 6.0% | 6.8% |
CooperSurgical | 40.4% | 97.0% | -45.8% | 68.7% | -46.1% | 19.3% | 26.0% | -4.9% |
Cost of goods sold | 1,168.8 | 966.7 | 896.1 | 896.6 | 900.5 | 773.2 | 793.7 | 726.8 |
Gross profit | 2,139.6 | 1,955.8 | 1,534.8 | 1,756.8 | 1,632.3 | 1,365.8 | 1,173.1 | 1,070.3 |
Gross margin | 64.7% | 66.9% | 63.1% | 66.2% | 64.4% | 63.9% | 59.6% | 59.6% |
Selling, general and administrative | 1,342.2 | 1,211.2 | 992.5 | 996.2 | 973.3 | 799.1 | 722.8 | 712.5 |
Research and development | 110.3 | 92.7 | 93.3 | 86.7 | 84.8 | 69.2 | 65.4 | 69.6 |
Other operating expenses | 10.3 | -66.1 | | | | | 60.8 | 51.5 |
EBITDA [+] | 843.4 | 881.2 | 598.9 | 808.9 | 702.6 | 617.5 | 522.4 | 428.1 |
EBITDA growth | -4.3% | 47.1% | -26.0% | 15.1% | 13.8% | 18.2% | 22.0% | -3.7% |
EBITDA margin | 25.5% | 30.2% | 24.6% | 30.5% | 27.7% | 28.9% | 26.6% | 23.8% |
Depreciation and amortization | 166.6 | 163.2 | 149.9 | 135.0 | 128.4 | 120.0 | 137.5 | 139.9 |
EBITA | 676.8 | 718.0 | 449.0 | 673.9 | 574.2 | 497.5 | 384.9 | 288.2 |
EBITA margin | 20.5% | 24.6% | 18.5% | 25.4% | 22.7% | 23.3% | 19.6% | 16.0% |
Amortization of intangibles | 179.5 | 146.1 | 137.2 | 145.8 | 146.7 | 68.4 | 60.8 | 51.5 |
EBIT [+] | 497.3 | 571.9 | 311.8 | 528.1 | 427.5 | 429.1 | 324.1 | 236.7 |
EBIT growth | -13.0% | 83.4% | -41.0% | 23.5% | -0.4% | 32.4% | 36.9% | -22.8% |
EBIT margin | 15.0% | 19.6% | 12.8% | 19.9% | 16.9% | 20.1% | 16.5% | 13.2% |
Non-recurring items [+] | -10.3 | 66.1 | | -18.6 | 24.4 | | | |
Asset impairment | | | | 0.4 | 24.4 | | | |
Loss (gain) on sale of assets | | | | -19.0 | | | | |
Interest expense | 57.3 | 23.1 | 36.8 | 68.0 | 82.7 | 33.4 | 26.2 | 18.1 |
Interest expense | 57.3 | 23.1 | 36.8 | 68.0 | 82.7 | 33.4 | 26.2 | 18.1 |
Other income (expense), net [+] | 25.0 | 8.8 | -8.5 | -1.3 | 11.5 | -1.7 | -2.3 | -3.1 |
Other | 25.0 | 8.8 | -8.5 | -1.3 | 11.5 | -1.7 | | |
Pre-tax income | 475.3 | 491.5 | 266.5 | 477.4 | 331.9 | 394.0 | 295.6 | 215.5 |
Income taxes | 89.5 | -2,453.2 | 28.1 | 10.7 | 192.0 | 21.1 | 20.7 | 10.4 |
Tax rate | 18.8% | | 10.5% | 2.2% | 57.8% | 5.4% | 7.0% | 4.8% |
Minority interest | | | | | | | 1.0 | 1.6 |
Net income | 385.8 | 2,944.7 | 238.4 | 466.7 | 139.9 | 372.9 | 273.9 | 203.5 |
Net margin | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% | 11.3% |
|
Basic EPS [+] | $7.83 | $59.85 | $4.86 | $9.45 | $2.85 | $7.63 | $5.65 | $4.20 |
Growth | -86.9% | 1132.7% | -48.6% | 231.6% | -62.6% | 35.0% | 34.6% | -25.3% |
Diluted EPS [+] | $7.76 | $59.13 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 |
Growth | -86.9% | 1130.2% | -48.5% | 231.6% | -62.6% | 34.5% | 35.1% | -25.0% |
|
Dividends per share [+] | $0.03 | $0.03 | $0.03 | $0.03 | $0.06 | $0.06 | $0.06 | $0.06 |
Growth | 0.0% | 0.0% | 0.0% | -49.2% | -0.4% | -0.8% | 0.0% | -0.4% |
|
Shares outstanding (basic) [+] | 49.3 | 49.2 | 49.1 | 49.4 | 49.1 | 48.9 | 48.5 | 48.5 |
Growth | 0.2% | 0.2% | -0.6% | 0.6% | 0.4% | 0.8% | 0.0% | 0.9% |
Shares outstanding (diluted) [+] | 49.7 | 49.8 | 49.6 | 50.0 | 49.7 | 49.6 | 49.0 | 49.2 |
Growth | -0.2% | 0.4% | -0.8% | 0.6% | 0.2% | 1.2% | -0.4% | 0.5% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|